ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals

被引:16
作者
Saito, M [1 ]
Eiraku, N
Usuku, K
Nobuhara, Y
Matsumoto, W
Kodama, D
Sabouri, AH
Izumo, S
Arimura, K
Osame, M
机构
[1] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriat, Kagoshima 8908520, Japan
[2] Kagoshima Univ, Hlth Serv Ctr, Kagoshima 8908580, Japan
[3] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Med Informat Sci, Kagoshima 8908520, Japan
[4] Kagoshima Univ, Ctr Chron Viral Dis, Dept Mol Pathol, Kagoshima 8908520, Japan
关键词
vitamin D receptor; single nucleotide polymorphism; HAM/TSP; HTLV-1; provirus load;
D O I
10.1016/j.jns.2005.01.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is one outcome of human T-cell lymphotropic virus type-1 (HTLV-1) infection. It remains unknown why the majority of infected people remain healthy, whereas only approximately 2-3% of infected individuals develop the disease. The active form of vitamin D has immunomodulatory effects, and allelic variants of the vitamin D receptor (VDR) appear to be associated with differential susceptibility to several infectious diseases. To investigate whether VDR single nucleotide polymorphisms (SNPs) are associated with the development of HAM/TSP, we studied four VDR SNPs in a group of 207 HAM/TSP patients and 224 asymptomatic HTLV-1 seropositive carriers (HCs) in Kagoshima, Japan, by using PCR-RFLP analysis. We found that ApaI polymorphism of VDR is associated with the risk of HANI/TSP, although this polymorphism did not affect the provirus load of HTLV-1 in either HAM/TSP patients or HCs. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 37 条
[1]   The immune response to HTLV-1 [J].
Bangham, CRM .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) :397-402
[2]   Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users [J].
Barber, Y ;
Rubio, C ;
Fernández, E ;
Rubio, M ;
Fibla, J .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10) :1279-1288
[3]   Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene [J].
Bellamy, R ;
Ruwende, C ;
Corrah, T ;
McAdam, KPWJ ;
Thursz, M ;
Whittle, HC ;
Hill, AVS .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03) :721-724
[4]  
BOMMAN L, 1989, J INFECT DIS, V190, P1631
[5]   Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians [J].
Collins, JE ;
Heward, JM ;
Nithiyananthan, R ;
Nejentsev, S ;
Todd, JA ;
Franklyn, JA ;
Gough, SCL .
CLINICAL ENDOCRINOLOGY, 2004, 60 (05) :618-624
[6]   Vitamin D: its role and uses in immunology [J].
Deluca, HF ;
Cantorna, MT .
FASEB JOURNAL, 2001, 15 (14) :2579-2585
[7]   PRODUCTION OF 1,25-DIHYDROXYVITAMIN-D3 BY HUMAN T-CELL LYMPHOTROPHIC VIRUS-I-TRANSFORMED LYMPHOCYTES [J].
FETCHICK, DA ;
BERTOLINI, DR ;
SARIN, PS ;
WEINTRAUB, ST ;
MUNDY, GR ;
DUNN, JF .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (02) :592-596
[8]   Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis [J].
Furukawa, Y ;
Yamashita, M ;
Usuku, K ;
Izumo, S ;
Nakagawa, M ;
Osame, M .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) :1343-1349
[9]  
GESSAIN A, 1985, LANCET, V2, P407
[10]   The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women [J].
Harris, SS ;
Eccleshall, TR ;
Gross, C ;
DawsonHughes, B ;
Feldman, D .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (07) :1043-1048